Risk of type III secretion systems in burn patients with Pseudomonas aeruginosa wound infection: A systematic review and meta-analysis.
Hasannejad-Bibalan M, Jafari A, Sabati H, Goswami R, Jafaryparvar Z, Sedaghat F, Sedigh Ebrahim-Saraie H.
Burns. 2021 May;47(3):538-544. doi: 10.1016/j.burns.2020.04.024. Epub 2020 May 21.
Nanophyto-gel against multi-drug resistant Pseudomonas aeruginosa burn wound infection.
Wen MM, Abdelwahab IA, Aly RG, El-Zahaby SA.
Drug Deliv. 2021 Dec;28(1):463-477. doi: 10.1080/10717544.2021.1889720.
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection.
de Vries CR, Sweere JM, Ishak H, Sunkari V, Bach MS, Liu D, Manasherob R, Bollyky PL.
J Vis Exp. 2020 Feb 20;(156):10.3791/60599. doi: 10.3791/60599.
The Immune Response to Chronic Pseudomonas aeruginosa Wound Infection in Immunocompetent Mice.
Sweere JM, Ishak H, Sunkari V, Bach MS, Manasherob R, Yadava K, Ruppert SM, Sen CK, Balaji S, Keswani SG, Secor PR, Bollyky PL.
Adv Wound Care (New Rochelle). 2020 Feb 1;9(2):35-47. doi: 10.1089/wound.2019.1039. Epub 2019 Dec 18.
The evolution of virulence in Pseudomonas aeruginosa during chronic wound infection.
Vanderwoude J, Fleming D, Azimi S, Trivedi U, Rumbaugh KP, Diggle SP.
Proc Biol Sci. 2020 Oct 28;287(1937):20202272. doi: 10.1098/rspb.2020.2272. Epub 2020 Oct 21.
A Standardized Mouse Model for Wound Infection with Pseudomonas aeruginosa.
Hou J, Wu Q, Xiong R, Malakar PK, Zhu Y, Zhao Y, Zhang Z.
Int J Mol Sci. 2024 Nov 1;25(21):11773. doi: 10.3390/ijms252111773.
Negative-Pressure Wound Therapy in a Pseudomonas aeruginosa Infection Model.
Wang G, Li Z, Li T, Wang S, Zhang L, Zhang L, Tang P.
Biomed Res Int. 2018 May 15;2018:9496183. doi: 10.1155/2018/9496183. eCollection 2018.
Evaluation of Pseudomonas aeruginosa pathogenesis and therapeutics in military-relevant animal infection models.
Bobrov AG, Getnet D, Swierczewski B, Jacobs A, Medina-Rojas M, Tyner S, Watters C, Antonic V.
APMIS. 2022 Jul;130(7):436-457. doi: 10.1111/apm.13119. Epub 2021 Jun 15.
A lipophilic chitosan-modified self-nanoemulsifying system influencing cellular membrane metabolism enhances antibacterial and anti-biofilm efficacy for multi-drug resistant Pseudomonas aeruginosa wound infection.
Cai D, Zhang Z, Feng Z, Song J, Zeng X, Tu Y, Zhao S, Luo X, Sun C, Yang Y, Liu X, Zou Q, Zeng H, Sun H.
Biomater Adv. 2022 Sep;140:213029. doi: 10.1016/j.bioadv.2022.213029. Epub 2022 Aug 3.
Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection.
Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M.
PLoS Genet. 2014 Jul 24;10(7):e1004518. doi: 10.1371/journal.pgen.1004518. eCollection 2014 Jul.
